Pharmosa Biopharm Inc. (TPEX:6875)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.80
+0.20 (0.33%)
Feb 14, 2025, 9:00 AM CST
-41.82%
Market Cap 7.85B
Revenue (ttm) 50.52M
Net Income (ttm) -292.93M
Shares Out 129.09M
EPS (ttm) -2.37
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 128,002
Average Volume 123,040
Open 60.50
Previous Close 60.60
Day's Range 60.10 - 61.60
52-Week Range 48.25 - 125.50
Beta 0.58
RSI 62.42
Earnings Date Feb 26, 2025

About Pharmosa Biopharm

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, T... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6875
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.